Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03

AUTHORS

A Rager, N Frey, S C Goldstein, R Reshef, E O Hexner, A Loren, S M Luger, A Perl, D Tsai, J Davis, M Vozniak, J Smith, E A Stadtmauer, D L Porter

ABSTRACT

Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2 mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed. More... »

PAGES

430

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2010.117

DOI

http://dx.doi.org/10.1038/bmt.2010.117

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001461507

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20498647


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rager", 
        "givenName": "A", 
        "id": "sg:person.01212723440.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212723440.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frey", 
        "givenName": "N", 
        "id": "sg:person.01342471137.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "S C", 
        "id": "sg:person.016115210252.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reshef", 
        "givenName": "R", 
        "id": "sg:person.01267452463.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hexner", 
        "givenName": "E O", 
        "id": "sg:person.01157065163.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157065163.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loren", 
        "givenName": "A", 
        "id": "sg:person.0613365041.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luger", 
        "givenName": "S M", 
        "id": "sg:person.012415664717.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perl", 
        "givenName": "A", 
        "id": "sg:person.0661500241.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661500241.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsai", 
        "givenName": "D", 
        "id": "sg:person.012706202757.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "J", 
        "id": "sg:person.0656420024.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656420024.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vozniak", 
        "givenName": "M", 
        "id": "sg:person.0724533224.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724533224.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "J", 
        "id": "sg:person.01004225563.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004225563.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "E A", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porter", 
        "givenName": "D L", 
        "id": "sg:person.0707416147.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-212290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001611407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/bbmt.2002.v8.pm12171485", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005360009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.20648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007210230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.20648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007210230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2005.05631.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008546660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703094", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011191594", 
          "https://doi.org/10.1038/sj.bmt.1703094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-03-0854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012449632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-12-041889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013110333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705762", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013865482", 
          "https://doi.org/10.1038/sj.bmt.1705762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2006.06321.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014592689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/bbmt.2002.v8.pm11939605", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018269103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2004.04856.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021868023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-11-4513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022078117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-01-0267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024061987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2009.05.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036851953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040041491", 
          "https://doi.org/10.1038/sj.bmt.1703032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2001.02582.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043256517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045806031", 
          "https://doi.org/10.1038/sj.bmt.1704929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2004.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046073242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02983793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047623985", 
          "https://doi.org/10.1007/bf02983793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02983793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047623985", 
          "https://doi.org/10.1007/bf02983793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-12-4241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052535770"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074566056", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076843321", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076963175", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078048643", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078474336", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078628577", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082422699", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03", 
    "datePublishedReg": "2011-03-01", 
    "description": "Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-\u03b1 are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2\u2009mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2010.117", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2420935", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "46"
      }
    ], 
    "name": "Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD", 
    "pagination": "430", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "06f63e2ed9815802c4b3e15df4dbe624deafa18d9e911f455d1058031ee6eda7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20498647"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2010.117"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001461507"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2010.117", 
      "https://app.dimensions.ai/details/publication/pub.1001461507"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000436.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bmt2010117"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'


 

This table displays all metadata directly associated to this object as RDF triples.

322 TRIPLES      21 PREDICATES      77 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2010.117 schema:about N0b803e71cdfb458e895c64450099acfe
2 N1d13987200a445c3b435dbb1f13dee91
3 N1da7107be40d454783784a16d005c542
4 N20b92601c9434fe2becc1a77967be7e1
5 N42f0bf114c09406783aee42def4939a0
6 N4b5c3ff4866d4ff289d5c78f3954fd50
7 N5fb175863ffe484cb92ca5a67c364cc3
8 N6c93bc04f865493099434e8691e40406
9 N757c01597c2c4cadac4f141092e66941
10 N76036745ea55403fa257bcca2ac60906
11 Nb8ff1edc672e471c9d9f7fde485ff602
12 Nbdab31f76ae1437cad2357921a279581
13 Nc72b4bbd62964525a21846ec6502b035
14 Nca6781fed8ca496a8d4571dad06afde6
15 Ncea4e06bec2a4bc8870e4aee39d0a5cf
16 Ncfe8d5f331294a35b80b18520717b033
17 Nd1f188149fc9476aa6a7963d1bd8a8d4
18 Nf8d752d4c76145faadac7f80438d1b17
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N9d53e2937b0542b8a035947a366b13fa
22 schema:citation sg:pub.10.1007/bf02983793
23 sg:pub.10.1038/sj.bmt.1703032
24 sg:pub.10.1038/sj.bmt.1703094
25 sg:pub.10.1038/sj.bmt.1704929
26 sg:pub.10.1038/sj.bmt.1705762
27 https://app.dimensions.ai/details/publication/pub.1074566056
28 https://app.dimensions.ai/details/publication/pub.1076843321
29 https://app.dimensions.ai/details/publication/pub.1076963175
30 https://app.dimensions.ai/details/publication/pub.1078048643
31 https://app.dimensions.ai/details/publication/pub.1078474336
32 https://app.dimensions.ai/details/publication/pub.1078628577
33 https://app.dimensions.ai/details/publication/pub.1082422699
34 https://doi.org/10.1002/pbc.20648
35 https://doi.org/10.1016/j.bbmt.2004.07.007
36 https://doi.org/10.1016/j.bbmt.2009.05.019
37 https://doi.org/10.1046/j.1365-2141.1997.1112925.x
38 https://doi.org/10.1046/j.1365-2141.2001.02582.x
39 https://doi.org/10.1053/bbmt.2002.v8.pm11939605
40 https://doi.org/10.1053/bbmt.2002.v8.pm12171485
41 https://doi.org/10.1080/01621459.1958.10501452
42 https://doi.org/10.1097/mph.0b013e31819daf60
43 https://doi.org/10.1111/j.1365-2141.2004.04856.x
44 https://doi.org/10.1111/j.1365-2141.2005.05631.x
45 https://doi.org/10.1111/j.1365-2141.2006.06321.x
46 https://doi.org/10.1182/blood-2003-01-0267
47 https://doi.org/10.1182/blood-2003-12-4241
48 https://doi.org/10.1182/blood-2004-03-0854
49 https://doi.org/10.1182/blood-2004-11-4513
50 https://doi.org/10.1182/blood-2006-12-041889
51 https://doi.org/10.1182/blood-2009-03-212290
52 schema:datePublished 2011-03
53 schema:datePublishedReg 2011-03-01
54 schema:description Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2 mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N4c12431c577942dba161b57073623e81
59 Nbaee0e68597f4f9eab8a99018c5534b8
60 sg:journal.1096890
61 schema:name Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
62 schema:pagination 430
63 schema:productId N45f46d2278be4587b39d4e6f618716f1
64 N880538c60515409db935b4a5e59e353f
65 Ne3223cb3b9924f0a91d5c13f8861ea76
66 Ned58cd649f934c49b2d4b7fcacaccbf6
67 Nf79efc61be634c0aa6dd48789b668975
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001461507
69 https://doi.org/10.1038/bmt.2010.117
70 schema:sdDatePublished 2019-04-10T18:09
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N5f6cbcd0c7864ca79f643c6a82bf864e
73 schema:url https://www.nature.com/articles/bmt2010117
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N06fec3b7d96c41a4bbca7e0234e3383d rdf:first sg:person.0613365041.61
78 rdf:rest Nc54a9ec6015146609ca776972f1ce0c7
79 N0b803e71cdfb458e895c64450099acfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Antibodies, Monoclonal, Humanized
81 rdf:type schema:DefinedTerm
82 N15ea27fa16844bc98a756ecf609c002b rdf:first sg:person.0724533224.87
83 rdf:rest N3647cef9e6cc4e75bc96ac15e2b032d0
84 N1d13987200a445c3b435dbb1f13dee91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Steroids
86 rdf:type schema:DefinedTerm
87 N1da7107be40d454783784a16d005c542 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Infliximab
89 rdf:type schema:DefinedTerm
90 N20b92601c9434fe2becc1a77967be7e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Female
92 rdf:type schema:DefinedTerm
93 N2337f21687e542b6bc090d93ee374722 rdf:first sg:person.01044042041.97
94 rdf:rest N9e29430502484b0b857eec7275a56d50
95 N28b4469b62174cb6b772ae7e26980f99 rdf:first sg:person.012706202757.24
96 rdf:rest N7a60e039f56d4b7e939c05da48422a81
97 N3647cef9e6cc4e75bc96ac15e2b032d0 rdf:first sg:person.01004225563.72
98 rdf:rest N2337f21687e542b6bc090d93ee374722
99 N42f0bf114c09406783aee42def4939a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Humans
101 rdf:type schema:DefinedTerm
102 N45f46d2278be4587b39d4e6f618716f1 schema:name readcube_id
103 schema:value 06f63e2ed9815802c4b3e15df4dbe624deafa18d9e911f455d1058031ee6eda7
104 rdf:type schema:PropertyValue
105 N4b5c3ff4866d4ff289d5c78f3954fd50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Immunoglobulin G
107 rdf:type schema:DefinedTerm
108 N4c12431c577942dba161b57073623e81 schema:volumeNumber 46
109 rdf:type schema:PublicationVolume
110 N4dab0c88659941b6974b8d402228948a rdf:first sg:person.01342471137.57
111 rdf:rest Nd2d0567c1b954566a0bff1dd97d359e5
112 N5f6cbcd0c7864ca79f643c6a82bf864e schema:name Springer Nature - SN SciGraph project
113 rdf:type schema:Organization
114 N5fb175863ffe484cb92ca5a67c364cc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adult
116 rdf:type schema:DefinedTerm
117 N6c93bc04f865493099434e8691e40406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 N757c01597c2c4cadac4f141092e66941 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Acute Disease
122 rdf:type schema:DefinedTerm
123 N76036745ea55403fa257bcca2ac60906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Survival Analysis
125 rdf:type schema:DefinedTerm
126 N7a60e039f56d4b7e939c05da48422a81 rdf:first sg:person.0656420024.61
127 rdf:rest N15ea27fa16844bc98a756ecf609c002b
128 N880538c60515409db935b4a5e59e353f schema:name nlm_unique_id
129 schema:value 8702459
130 rdf:type schema:PropertyValue
131 N9c86cc2399af4c00be52a773ee2f72d7 rdf:first sg:person.0661500241.33
132 rdf:rest N28b4469b62174cb6b772ae7e26980f99
133 N9d53e2937b0542b8a035947a366b13fa rdf:first sg:person.01212723440.81
134 rdf:rest N4dab0c88659941b6974b8d402228948a
135 N9e29430502484b0b857eec7275a56d50 rdf:first sg:person.0707416147.15
136 rdf:rest rdf:nil
137 Nb89bea9980a846b4945e923ef35f0319 rdf:first sg:person.01267452463.62
138 rdf:rest Nde711f24b39b4eb585493e32e7750fbf
139 Nb8ff1edc672e471c9d9f7fde485ff602 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Treatment Outcome
141 rdf:type schema:DefinedTerm
142 Nbaee0e68597f4f9eab8a99018c5534b8 schema:issueNumber 3
143 rdf:type schema:PublicationIssue
144 Nbdab31f76ae1437cad2357921a279581 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Antibodies, Monoclonal
146 rdf:type schema:DefinedTerm
147 Nc54a9ec6015146609ca776972f1ce0c7 rdf:first sg:person.012415664717.68
148 rdf:rest N9c86cc2399af4c00be52a773ee2f72d7
149 Nc72b4bbd62964525a21846ec6502b035 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Drug Resistance
151 rdf:type schema:DefinedTerm
152 Nca6781fed8ca496a8d4571dad06afde6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Immunosuppressive Agents
154 rdf:type schema:DefinedTerm
155 Ncea4e06bec2a4bc8870e4aee39d0a5cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Male
157 rdf:type schema:DefinedTerm
158 Ncfe8d5f331294a35b80b18520717b033 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Prognosis
160 rdf:type schema:DefinedTerm
161 Nd1f188149fc9476aa6a7963d1bd8a8d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Retrospective Studies
163 rdf:type schema:DefinedTerm
164 Nd2d0567c1b954566a0bff1dd97d359e5 rdf:first sg:person.016115210252.03
165 rdf:rest Nb89bea9980a846b4945e923ef35f0319
166 Nde711f24b39b4eb585493e32e7750fbf rdf:first sg:person.01157065163.51
167 rdf:rest N06fec3b7d96c41a4bbca7e0234e3383d
168 Ne3223cb3b9924f0a91d5c13f8861ea76 schema:name pubmed_id
169 schema:value 20498647
170 rdf:type schema:PropertyValue
171 Ned58cd649f934c49b2d4b7fcacaccbf6 schema:name doi
172 schema:value 10.1038/bmt.2010.117
173 rdf:type schema:PropertyValue
174 Nf79efc61be634c0aa6dd48789b668975 schema:name dimensions_id
175 schema:value pub.1001461507
176 rdf:type schema:PropertyValue
177 Nf8d752d4c76145faadac7f80438d1b17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Graft vs Host Disease
179 rdf:type schema:DefinedTerm
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
184 schema:name Clinical Sciences
185 rdf:type schema:DefinedTerm
186 sg:grant.2420935 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2010.117
187 rdf:type schema:MonetaryGrant
188 sg:journal.1096890 schema:issn 0268-3369
189 1476-5365
190 schema:name Bone Marrow Transplantation
191 rdf:type schema:Periodical
192 sg:person.01004225563.72 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
193 schema:familyName Smith
194 schema:givenName J
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004225563.72
196 rdf:type schema:Person
197 sg:person.01044042041.97 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
198 schema:familyName Stadtmauer
199 schema:givenName E A
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
201 rdf:type schema:Person
202 sg:person.01157065163.51 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
203 schema:familyName Hexner
204 schema:givenName E O
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157065163.51
206 rdf:type schema:Person
207 sg:person.01212723440.81 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
208 schema:familyName Rager
209 schema:givenName A
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212723440.81
211 rdf:type schema:Person
212 sg:person.012415664717.68 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
213 schema:familyName Luger
214 schema:givenName S M
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68
216 rdf:type schema:Person
217 sg:person.01267452463.62 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
218 schema:familyName Reshef
219 schema:givenName R
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62
221 rdf:type schema:Person
222 sg:person.012706202757.24 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
223 schema:familyName Tsai
224 schema:givenName D
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24
226 rdf:type schema:Person
227 sg:person.01342471137.57 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
228 schema:familyName Frey
229 schema:givenName N
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57
231 rdf:type schema:Person
232 sg:person.016115210252.03 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
233 schema:familyName Goldstein
234 schema:givenName S C
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03
236 rdf:type schema:Person
237 sg:person.0613365041.61 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
238 schema:familyName Loren
239 schema:givenName A
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61
241 rdf:type schema:Person
242 sg:person.0656420024.61 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
243 schema:familyName Davis
244 schema:givenName J
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656420024.61
246 rdf:type schema:Person
247 sg:person.0661500241.33 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
248 schema:familyName Perl
249 schema:givenName A
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661500241.33
251 rdf:type schema:Person
252 sg:person.0707416147.15 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
253 schema:familyName Porter
254 schema:givenName D L
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15
256 rdf:type schema:Person
257 sg:person.0724533224.87 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
258 schema:familyName Vozniak
259 schema:givenName M
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724533224.87
261 rdf:type schema:Person
262 sg:pub.10.1007/bf02983793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047623985
263 https://doi.org/10.1007/bf02983793
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/sj.bmt.1703032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040041491
266 https://doi.org/10.1038/sj.bmt.1703032
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/sj.bmt.1703094 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011191594
269 https://doi.org/10.1038/sj.bmt.1703094
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/sj.bmt.1704929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045806031
272 https://doi.org/10.1038/sj.bmt.1704929
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/sj.bmt.1705762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013865482
275 https://doi.org/10.1038/sj.bmt.1705762
276 rdf:type schema:CreativeWork
277 https://app.dimensions.ai/details/publication/pub.1074566056 schema:CreativeWork
278 https://app.dimensions.ai/details/publication/pub.1076843321 schema:CreativeWork
279 https://app.dimensions.ai/details/publication/pub.1076963175 schema:CreativeWork
280 https://app.dimensions.ai/details/publication/pub.1078048643 schema:CreativeWork
281 https://app.dimensions.ai/details/publication/pub.1078474336 schema:CreativeWork
282 https://app.dimensions.ai/details/publication/pub.1078628577 schema:CreativeWork
283 https://app.dimensions.ai/details/publication/pub.1082422699 schema:CreativeWork
284 https://doi.org/10.1002/pbc.20648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007210230
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/j.bbmt.2004.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046073242
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.bbmt.2009.05.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036851953
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1046/j.1365-2141.1997.1112925.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000437859
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1046/j.1365-2141.2001.02582.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043256517
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1053/bbmt.2002.v8.pm11939605 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018269103
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1053/bbmt.2002.v8.pm12171485 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005360009
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1097/mph.0b013e31819daf60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007688274
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1111/j.1365-2141.2004.04856.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021868023
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1111/j.1365-2141.2005.05631.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008546660
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1111/j.1365-2141.2006.06321.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014592689
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1182/blood-2003-01-0267 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024061987
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1182/blood-2003-12-4241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052535770
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1182/blood-2004-03-0854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012449632
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1182/blood-2004-11-4513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022078117
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1182/blood-2006-12-041889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013110333
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1182/blood-2009-03-212290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001611407
319 rdf:type schema:CreativeWork
320 https://www.grid.ac/institutes/grid.412713.2 schema:alternateName Penn Presbyterian Medical Center
321 schema:name Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA
322 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...